HomeURGN • NASDAQ
Urogen Pharma Ltd
Follow
$10.90
0.74%
After Hours:(0.00%)0.00
$10.90
Closed: Mar 13, 4:00:04 PM GMT-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 24.57M | 4.40% |
Operating expense | 48.65M | 35.70% |
Net income | -37.51M | -44.19% |
Net profit margin | -152.71 | -38.11% |
Earnings per share | -0.80 | -11.11% |
EBITDA | -26.49M | -83.72% |
Effective tax rate | -7.60% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 236.69M | 72.80% |
Total assets | 285.71M | 60.23% |
Total liabilities | 294.51M | 20.94% |
Total equity | -8.80M | — |
Shares outstanding | 46.09M | — |
Price to book | -51.52 | — |
Return on assets | -22.60% | — |
Return on capital | -50.23% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -37.51M | -44.19% |
Cash from operations | -13.62M | -4.79% |
Cash from investing | 60.62M | 634.39% |
Cash from financing | 71.00K | 77.50% |
Net change in cash | 47.07M | 293.72% |
Free cash flow | 1.69M | 195.34% |
Previous close
$10.82
Day range
$10.68 - $11.14
Year range
$9.03 - $20.70
Market cap
459.97M USD
Avg Volume
381.68K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2004
Headquarters
Website
Employees
235
